Analysis of Cardiac Biomarkers, ECG and CPET Results in Children With Cardiomyopathies

Katarzyna Łuczak-Woźniak

Status

Active, not recruiting

Conditions

Cardiomyopathies

Treatments

Diagnostic Test: ECG

Diagnostic Test: 24-hour ECG monitoring

Diagnostic Test: Cardiac biomarkers

Diagnostic Test: Cardio-pulmonary exercise test (CPET)

Study type

Observational

Funder types

Other

Identifiers

NCT04316923

WUM CM

Details and patient eligibility

About

The aim of the study is to analyze cardiac biomarkers, electrocardiograms and cardio-pulmonary exercise test (CPET) results in children with cardiomyopathies.

Full description

The study group will consist of children that have been diagnosed with DCM, HCM or LVNC. The control group will be composed of healthy children. Examination of cardiac biomarkers (in the study group), ECG, 24-hour- ECG monitoring, CPET will be performed.

Patients in the study group will be invited for 2 consecutive visits (in 6-10 months intervals). During the first and the last visit CPET will be performed. The control group will not be invited for consecutive visits.

Enrollment

80 estimated patients

Sex

All

Ages

1 day to 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Children with HCM, DCM, LVNC diagnosed in 2D echo.
Healthy children with no congenital heart disease (CHD) in 2D echo.
Patients who signed consent form.

Exclusion criteria

Patients with coexisting CHD, kidney and liver disfunction, taking anti-psychotic and anti-depressant medication, or patients with bundle bunch blocks in ECG.
no consent form signed.